Overexpression of ERCC3 is associated with poor prognosis in patients with pancreatic cancer

Pancreatic cancer is associated with poor prognosis due to limited therapeutic options. Excision repair cross-complementing 3 (ERCC3) is an important member of nucleotide excision repair (NER) that is overexpressed in some cancers and may be regarded as a poor prognostic factor. Yet, its role in pan...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:J Cancer
Glavni autori: Wang, Shujie, Liu, Wenjing, Ni, Yueli, Wang, Lifeng, Zhu, Yuzhi, Shi, Qiong, Yi, Zihan, Wang, Wenjie, Liu, Lili, Yang, Lijuan, Kuang, Yingmin, Zhu, Yuechun, Zhang, Qiao, Yang, Zhe
Format: Artigo
Jezik:Inglês
Izdano: Ivyspring International Publisher 2021
Teme:
Research Paper
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC8040713/
https://ncbi.nlm.nih.gov/pubmed/33854616
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/jca.54576
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items